background image

Moderna Clinical Trials

Find clinical trials for Moderna. Search for Moderna clinical trials in different cities and states across the United States.

Filter

COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases

Recruiting
PHASE2
PHASE3

Sponsor:

Paul R Fortin

Location:

Montreal, Quebec

Code:

NCT05236491

Conditions

Rheumatoid Arthritis

Autoimmune Rheumatologic Disease

Systemic Lupus Erythematosus

Systemic Vasculitis

Systemic Sclerosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

COVID-19 vaccine

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

Recruiting
PHASE2

Sponsor:

Moderna

Location:

Boston

Code:

NCT05683457

Conditions

Cytomegalovirus Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

mRNA-1647

Placebo

A Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia

Recruiting
PHASE1
PHASE2

Sponsor:

Moderna

Location:

Los Angeles, Palo Alto, Philadelphia, Edmontonshow 1 more

Code:

NCT04899310

Conditions

Methylmalonic Acidemia

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

Interventions

mRNA-3705

COVID-19 Vaccines Safety Tracking (CoVaST)

Recruiting

Sponsor:

Masaryk University

Location:

Philadelphia, Hamilton

Code:

NCT04834869

Conditions

Adverse Reaction to Vaccine

COVID19 Vaccine

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BNT162b2

mRNA-1273

AZD1222

CoronaVac

Sinopharm

National Vaccine Adverse Event Reporting Survey and Etiology

Recruiting

Sponsor:

Neuroganics LLC

Location:

Northglenn

Code:

NCT05095844

Conditions

COVID-19

Vaccine Adverse Reaction

Vaccine Reaction

Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use

Corona Virus Infection

Eligibility Criteria

Sex: All

Age: 5 - 70+

Healthy Volunteers: Not accepted

Interventions

vaccinated

Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

Recruiting
PHASE1
PHASE2

Sponsor:

Moderna

Location:

Los Angeles, Stanford, Baltimore, Bostonshow 8 more

Code:

NCT04159103

Conditions

Propionic Acidemia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

mRNA-3927

An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

Recruiting
PHASE2

Sponsor:

Moderna

Location:

Tucson, San Francisco, Santa Monica, Aurorashow 11 more

Code:

NCT03897881

Conditions

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

mRNA-4157

Pembrolizumab

Vaccine Responses in Patients With B Cell Malignancies

Recruiting

Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Location:

Bethesda

Code:

NCT05170399

Conditions

Lymphoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Fluzone

Shingrix

Flucelvax

Afluria

PREVNAR 13

A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

Recruiting
PHASE1
PHASE2

Sponsor:

Moderna

Location:

Ann Arbor, Durham, Philadelphia, Toronto

Code:

NCT05130437

Conditions

Propionic Acidemia

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

Interventions

mRNA-3927

An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705

Recruiting
PHASE1
PHASE2

Sponsor:

Moderna

Location:

Los Angeles, Palo Alto, Edmonton, Toronto

Code:

NCT05295433

Conditions

Methylmalonic Acidemia

Eligibility Criteria

Sex: All

Age: 1+

Healthy Volunteers: Not accepted

Interventions

mRNA-3705